Skip to content

Addiction: A Futuristics Perspective

Presented by Omar Manejwala, MD

Presenter Bio

Omar is a leading expert on behavior change. His career is characterized by developing, piloting, and commercializing scalable solutions that drive durable behavior change in chronic disease. At Dario he leads the company’s clinical solutions and provides visible external and internal leadership, developing and maintaining c-level health plan relationships, conducting our clinical research, vetting clinical partnerships, and setting clinical product strategy to drive clinical and financial outcomes. Close partnership with digital product in Dario’s agile environment has led to best-of-suite solutions with industry-leading outcomes.

Previous roles include Chief Medical Officer of Catasys where he led Product from zero to pilots and then to commercial scale, securing contracts for the program with most of the largest health plans in the US and several regional plans and offering services in 28 states. He has developed and scaled solutions for commercial, exchange, managed Medicare Advantage, and managed Medicaid adult populations as well as employer markets. Innovative products and clinical protocols he developed are helping thousands of people get the care they desperately need to improve their health and reduce their overall costs. These solutions and partnerships are directly responsible for Catasys growth from zero to an approximately $1.5 billion valuation at peak.

Prior to that, he held various leadership roles most recently as Medical Director at Hazelden. He has an MBA from the University of Virginia’s Darden School of Business, an M.D. from the University of Maryland School of Medicine and served as Executive Chief Resident in Psychiatry at Duke University. He is a Distinguished Fellow of the American Psychiatric Association, a Fellow of the American Society of Addiction Medicine, and board certified in Psychiatry, Addiction Medicine and Medical Management. He is the recipient of numerous awards and the author of several publications including the best-selling book Craving: Why We Can’t Seem to Get Enough (Hazelden Pub 2013). To learn more about Dr. Manejwala personally, visit and to learn more about DarioHealth visit

Healthcare in general, and addiction treatment specifically, are poised to experience dramatic shifts over the next 5-10 years. Increasing payer pressure to capture, report and improve outcomes, and to control costs and alter the trajectory of the illness will result in wholesale shifts in the way addictions are managed. Broader societal goals of increasing access to care, improving the efficacy and utilization of screening, prevent the onset of these disorders, and manage the widespread criminalization of substance use disorders can be achieved if philosophical objections and technological hurdles can be negotiated.

In this talk, a futurists perspective on addiction will be presented, with an eye to briefly describing the forces that led us to our current state and describing changes that might allow us to navigate to improved global addiction outcomes. In particular, an emphasis on broader, well-defined principles of healthcare innovation and their potential application to addiction will be discussed. Attendees will leave with a broader perspective on how they themselves can participate in defining the future of addiction treatment.

Course Objectives

At the conclusion of the presentation, attendees will be able to:

  1. Describe several trends in addiction epidemiology, prevention and treatment, and describe potential future trajectories
  2. List sociopolitical forces that may serve to shape future approaches to addiction management
  3. Analyze the role of “big data” in defining future approaches to addiction management
  4. Identify potential technological innovations and their impact on addictions, including, for example, developments in AI such as ChatGPT
  5. Describe the central features of healthcare innovation and propose how these might manifest in the future of addiction prevention and treatment

Instructional Level


Licensed mental health professionals employed through Kaiser Permanente and psychological assistants performing under supervision of a licensed psychologist.

This CE program is free to Kaiser Permanente employees.
Instructional Methodology
On-line Presentation

Continuing Education Information

Kaiser Permanente Northern California Mental Health Training Program is approved by the California Psychological Association to provide continuing professional education for psychologists. The Kaiser Permanente Northern California Mental Health Training Program maintains responsibility for this program and its content.

Refund and Attendance Policy

All programs offered on KP Learn for CE credit through the KP Northern California Mental Health Training website are free of charge to Kaiser Permanente Staff and trainees. Once a course is selected in the KP NCAL MH Training Website, the registration process begins, and it will appear in the individuals KP Learn profile for completion within 90 days.

IMPORTANT NOTICE: Those who attend the program in full and complete the appropriate evaluation form will receive CE credits. Please note that credit will only be granted to those who attend the entire program. An attestation of attendance will be given once the individual has completed viewing the program, which will then initiate the final steps of completing the evaluation forms to receive a certificate of completion.

Back To Top